正川股份: 2025年半年度报告摘要

Core Viewpoint - Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd. reported a significant decline in financial performance for the first half of 2025, with a notable drop in revenue and net profit compared to the previous year [1]. Financial Summary - Total assets decreased by 4% to CNY 1,878,591,582.15 from CNY 1,956,811,650.01 at the end of the previous year [1]. - Net assets attributable to shareholders decreased by 1.89% to CNY 1,200,300,504.04 from CNY 1,223,406,926.68 [1]. - Operating revenue fell by 29.75% to CNY 323,667,653.98 from CNY 460,712,684.97 in the same period last year [1]. - Total profit decreased by 69.24% to CNY 15,483,078.44 from CNY 50,342,263.49 [1]. - Net profit attributable to shareholders dropped by 68.26% to CNY 14,088,294.45 from CNY 44,379,764.42 [1]. - Net cash flow from operating activities increased by 89.31% to CNY 59,361,293.64 from CNY 31,356,251.65 [1]. - The weighted average return on net assets decreased by 2.44 percentage points to 1.16% from 3.60% [1]. - Basic and diluted earnings per share decreased by 68.97% to CNY 0.09 from CNY 0.29 [1]. Shareholder Information - The total number of shareholders as of the reporting period was 18,889 [1]. - The largest shareholder, Chongqing Zhengchuan Investment Co., Ltd., holds 39.07% of the shares [2]. - Key individuals among the top shareholders include Deng Yong (19.38%), Deng Qiuhan (3.65%), and Deng Bulin (3.20%) [2][3].